Takeda Files For Approval Of First PPI And Low-Dose Aspirin Combination In Japan
This article was originally published in PharmAsia News
Executive Summary
Takeda filed an application for the approval of a combination of the peptic ulcer drug Takepron (lansoprazole) and a low dose of aspirin on March 27 in Japan.